Pluronic-based micelle encapsulation potentiates myricetin-induced cytotoxicity in human glioblastoma cells

Xiang-Jun Tang,1,* Kuan-Ming Huang,1,* Hui Gui,1,* Jun-Jie Wang,2 Jun-Ti Lu,1 Long-Jun Dai,1,3 Li Zhang,1 Gang Wang2 1Department of Neurosurgery, TaiHe Hospital, Hubei University of Medicine, Shiyan, 2Department of Pharmaceutics, Shanghai Eighth People’s Hospital, Jiangsu University, Shan...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Tang XJ, Huang KM, Gui H, Wang JJ, Lu JT, Dai LJ, Zhang L, Wang G
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2016
Materias:
Acceso en línea:https://doaj.org/article/0e55860e3f1a452987344088d7634464
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:0e55860e3f1a452987344088d7634464
record_format dspace
spelling oai:doaj.org-article:0e55860e3f1a452987344088d76344642021-12-02T02:31:38ZPluronic-based micelle encapsulation potentiates myricetin-induced cytotoxicity in human glioblastoma cells1178-2013https://doaj.org/article/0e55860e3f1a452987344088d76344642016-10-01T00:00:00Zhttps://www.dovepress.com/pluronic-based-micelle-encapsulation-potentiates-myricetin-induced-cyt-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Xiang-Jun Tang,1,* Kuan-Ming Huang,1,* Hui Gui,1,* Jun-Jie Wang,2 Jun-Ti Lu,1 Long-Jun Dai,1,3 Li Zhang,1 Gang Wang2 1Department of Neurosurgery, TaiHe Hospital, Hubei University of Medicine, Shiyan, 2Department of Pharmaceutics, Shanghai Eighth People’s Hospital, Jiangsu University, Shanghai, People’s Republic of China; 3Department of Surgery, University of British Columbia, Vancouver, BC, Canada *These authors contributed equally to this work Abstract: As one of the natural herbal flavonoids, myricetin has attracted much research interest, mainly owing to its remarkable anticancer properties and negligible side effects. It holds great potential to be developed as an ideal anticancer drug through improving its bioavailability. This study was performed to investigate the effects of Pluronic-based micelle encapsulation on myricetin-induced cytotoxicity and the mechanisms underlying its anticancer properties in human glioblastoma cells. Cell viability was assessed using a methylthiazol tetrazolium assay and a real-time cell analyzer. Immunoblotting and quantitative reverse transcriptase polymerase chain reaction techniques were used for determining the expression levels of related molecules in protein and mRNA. The results indicated that myricetin-induced cytotoxicity was highly potentiated by the encapsulation of myricetin. Mitochondrial apoptotic pathway was demonstrated to be involved in myricetin-induced glioblastoma cell death. The epidermal growth factor receptor (EGFR)/PI3K/Akt pathway located in the plasma membrane and cytosol and the RAS-ERK pathway located in mitochondria served as upstream and downstream targets, respectively, in myricetin-induced apoptosis. MiR-21 inhibitors interrupted the expression of EGFR, p-Akt, and K-Ras in the same fashion as myricetin-loaded mixed micelles (MYR-MCs) and miR-21 expression were dose-dependently inhibited by MYR-MCs, indicating the interaction of miR-21 with MYR-MCs. This study provided evidence supportive of further development of MYR-MC formulation for preferentially targeting mitochondria of glioblastoma cells. Keywords: myricetin, glioblastoma, EGFR, miR-21, mitochondrial apoptosis, mixed micelles, anticancer, drug deliveryTang XJHuang KMGui HWang JJLu JTDai LJZhang LWang GDove Medical PressarticleMyricetinglioblastomaEGFRmiR-21mitochondrial apoptosismixed micellesMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 11, Pp 4991-5002 (2016)
institution DOAJ
collection DOAJ
language EN
topic Myricetin
glioblastoma
EGFR
miR-21
mitochondrial apoptosis
mixed micelles
Medicine (General)
R5-920
spellingShingle Myricetin
glioblastoma
EGFR
miR-21
mitochondrial apoptosis
mixed micelles
Medicine (General)
R5-920
Tang XJ
Huang KM
Gui H
Wang JJ
Lu JT
Dai LJ
Zhang L
Wang G
Pluronic-based micelle encapsulation potentiates myricetin-induced cytotoxicity in human glioblastoma cells
description Xiang-Jun Tang,1,* Kuan-Ming Huang,1,* Hui Gui,1,* Jun-Jie Wang,2 Jun-Ti Lu,1 Long-Jun Dai,1,3 Li Zhang,1 Gang Wang2 1Department of Neurosurgery, TaiHe Hospital, Hubei University of Medicine, Shiyan, 2Department of Pharmaceutics, Shanghai Eighth People’s Hospital, Jiangsu University, Shanghai, People’s Republic of China; 3Department of Surgery, University of British Columbia, Vancouver, BC, Canada *These authors contributed equally to this work Abstract: As one of the natural herbal flavonoids, myricetin has attracted much research interest, mainly owing to its remarkable anticancer properties and negligible side effects. It holds great potential to be developed as an ideal anticancer drug through improving its bioavailability. This study was performed to investigate the effects of Pluronic-based micelle encapsulation on myricetin-induced cytotoxicity and the mechanisms underlying its anticancer properties in human glioblastoma cells. Cell viability was assessed using a methylthiazol tetrazolium assay and a real-time cell analyzer. Immunoblotting and quantitative reverse transcriptase polymerase chain reaction techniques were used for determining the expression levels of related molecules in protein and mRNA. The results indicated that myricetin-induced cytotoxicity was highly potentiated by the encapsulation of myricetin. Mitochondrial apoptotic pathway was demonstrated to be involved in myricetin-induced glioblastoma cell death. The epidermal growth factor receptor (EGFR)/PI3K/Akt pathway located in the plasma membrane and cytosol and the RAS-ERK pathway located in mitochondria served as upstream and downstream targets, respectively, in myricetin-induced apoptosis. MiR-21 inhibitors interrupted the expression of EGFR, p-Akt, and K-Ras in the same fashion as myricetin-loaded mixed micelles (MYR-MCs) and miR-21 expression were dose-dependently inhibited by MYR-MCs, indicating the interaction of miR-21 with MYR-MCs. This study provided evidence supportive of further development of MYR-MC formulation for preferentially targeting mitochondria of glioblastoma cells. Keywords: myricetin, glioblastoma, EGFR, miR-21, mitochondrial apoptosis, mixed micelles, anticancer, drug delivery
format article
author Tang XJ
Huang KM
Gui H
Wang JJ
Lu JT
Dai LJ
Zhang L
Wang G
author_facet Tang XJ
Huang KM
Gui H
Wang JJ
Lu JT
Dai LJ
Zhang L
Wang G
author_sort Tang XJ
title Pluronic-based micelle encapsulation potentiates myricetin-induced cytotoxicity in human glioblastoma cells
title_short Pluronic-based micelle encapsulation potentiates myricetin-induced cytotoxicity in human glioblastoma cells
title_full Pluronic-based micelle encapsulation potentiates myricetin-induced cytotoxicity in human glioblastoma cells
title_fullStr Pluronic-based micelle encapsulation potentiates myricetin-induced cytotoxicity in human glioblastoma cells
title_full_unstemmed Pluronic-based micelle encapsulation potentiates myricetin-induced cytotoxicity in human glioblastoma cells
title_sort pluronic-based micelle encapsulation potentiates myricetin-induced cytotoxicity in human glioblastoma cells
publisher Dove Medical Press
publishDate 2016
url https://doaj.org/article/0e55860e3f1a452987344088d7634464
work_keys_str_mv AT tangxj pluronicbasedmicelleencapsulationpotentiatesmyricetininducedcytotoxicityinhumanglioblastomacells
AT huangkm pluronicbasedmicelleencapsulationpotentiatesmyricetininducedcytotoxicityinhumanglioblastomacells
AT guih pluronicbasedmicelleencapsulationpotentiatesmyricetininducedcytotoxicityinhumanglioblastomacells
AT wangjj pluronicbasedmicelleencapsulationpotentiatesmyricetininducedcytotoxicityinhumanglioblastomacells
AT lujt pluronicbasedmicelleencapsulationpotentiatesmyricetininducedcytotoxicityinhumanglioblastomacells
AT dailj pluronicbasedmicelleencapsulationpotentiatesmyricetininducedcytotoxicityinhumanglioblastomacells
AT zhangl pluronicbasedmicelleencapsulationpotentiatesmyricetininducedcytotoxicityinhumanglioblastomacells
AT wangg pluronicbasedmicelleencapsulationpotentiatesmyricetininducedcytotoxicityinhumanglioblastomacells
_version_ 1718402390210641920